Select Publications
Conference Abstracts
2021, 'Successful treatment of hypocomplementaemic urticarial vasculitis syndrome (HUVS) with omalizumab', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 103 - 103, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700254&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Successful treatment of hypocomplementaemic urticarial vasculitis syndrome (HUVS) with omalizumab', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Ustekinumab and tildrakizumab in pyoderma gangrenosum', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 114 - 115, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700284&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Which outcome measures are the best for clinical trials in Epidermolysis Bullosa?', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 110 - 111, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Results from ADVISE: a randomized, double-blind, placebo-controlled phase II study of etrasimod, an oral, selective, sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis', in BRITISH JOURNAL OF DERMATOLOGY, WILEY, Vol. 184, pp. E85 - E85, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000625508500052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, '415 Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease (AIBD) using the Glucocorticoid Toxicity Index (GTI)', in Journal of Investigative Dermatology, Elsevier BV, Vol. 141, pp. S72 - S72, http://dx.doi.org/10.1016/j.jid.2021.02.438
,2020, 'DIACEREIN 1% OINTMENT FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA SIMPLEX: RESULTS OF A PHASE 2 STUDY', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 46 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'DRY EYE DISEASE IDENTIFIED IN A PROSPECTIVE STUDY OF OCULAR INVOLVEMENT IN EPIDERMOLYSIS BULLOSA AND AUTOIMMUNE BLISTERING DISEASES', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 78 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'EPIDERMOLYSIS BULLOSA RELEVANT ENDPOINTS - A DEBATE', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 15 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'REVIEW OF HAIR DISORDERS AND ALOPECIA IN EPIDERMOLYSIS BULLOSA DISEASE GROUP: A NEGLECTED AREA OF CARE', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'TOPICAL THERAPIES FOR EPIDERMOLYSIS BULLOSA', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 9 - 9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'WHICH OUTCOME MEASURES ARE THE BEST FOR CLINICAL TRIALS IN EPIDERMOLYSIS BULLOSA?', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Dry eye disease identified in a prospective study of ocular manifestations in Inherited Epidermolysis Bullosa and Autoimmune Blistering Diseases', in CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, WILEY, Vol. 47, pp. 113 - 114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493279000184&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Prospective study of the ocular manifestations in Epidermolysis Bullosa and Autoimmune Blistering Diseases identifies Dry Eye Disease', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, CANADA, Vancouver, Vol. 60, presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), CANADA, Vancouver, 28 April 2019 - 02 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488800703057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Pathogenesis and clinical features of alopecia in epidermolysis bullosa: A systematic review', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, DC, Washington, Vol. 81, pp. AB99 - AB99, presented at Annual Meeting of the American-Academy-of-Dermatology (AAD), DC, Washington, 01 March 2019 - 05 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000482195001010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Omalizumab shows variable efficacy in the treatment of bullous pemphigoid', in BRITISH JOURNAL OF DERMATOLOGY, WILEY, ENGLAND, RCP, London, Vol. 180, pp. E146 - E147, presented at 14th Annual Medical Dermatology Meeting, ENGLAND, RCP, London, 17 January 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000466806400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'A case-control study on the environmental triggers of autoimmune blistering disease', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 37 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Ocular complications of pemphigus, pemphigoid and epidermolysis bullosa acquisita: A prospective study', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Thalidomide and doxycycline in the management of junctional epidermolysis bullosa laryngo-onycho-cutaneous syndrome (JEB-LOC)', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Updates to scoring tools for grading severity of disease in chronic cutaneous blistering diseases', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 83 - 83, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Urticarial vasculitis dependent on systemic steroids: Complete therapeutic response to omalizumab', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 54 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Validation of the BIOCHIP as a diagnostic tool for pemphigus vulgaris and foliaceus in Australia', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 125 - 125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100346&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Prospective study on the ocular manifestations in Epidermolysis Bullosa and Autoimmune Blistering Diseases.', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, HI, Honolulu, Vol. 59, presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), HI, Honolulu, 29 April 2018 - 03 May 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000442912500129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'A study of the number of female editors-in-chief of dermatology journals', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 58, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Contributions of the independent learning programme at University of New South Wales to dermatology registrar training 2006-2016', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 58, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Patient and practitioner satisfaction with tele-dermatology including Australia's indigenous population', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 58, pp. 66 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100193&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Sirolimus-associated scrotal lymphedema and secondary development of lymphangiomatosis: Successful treatment with shave excision and cauterization', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 58, pp. 65 - 65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100191&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Determination of the best objective clinical outcome measure for bullous pemphigoid', in Australasian Journal of Dermatology, Wiley: 12 months, Noosa, Queensland, Australia, Vol. 57, pp. 33 - 33, presented at Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, Queensland, Australia, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1016/j.jaad.2011.06.032
,2016, 'Fear of topical corticosteroids within Australian atopic dermatitis patients', in Australasian Journal of Dermatology, Wiley: 12 months, Perth, Western Australia, Vol. 57, pp. 18 - 18, presented at Australasian College of Dermatologists 49th Annual Scientific Meeting, Perth, Western Australia, 14 May 2016 - 17 May 2016, http://dx.doi.org/10.1111/ajd.12480/epdf
,2016, 'Phenotypic heterogeneity in a family with dystrophic epidermolysis bullosa: A genotypic variation?', in Australasian Journal of Dermatology, Wiley: 12 months, Perth, Western Australia, Vol. 57, pp. 17 - 17, presented at Australasian College of Dermatologists 49th Annual Scientific Meeting, Perth, Western Australia, 14 May 2016 - 17 May 2016, http://dx.doi.org/10.1111/ajd.12480/epdf
,2016, 'Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa in Australasia: 1991-2015', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, AZ, Scottsdale, Vol. 136, pp. S25 - S25, presented at Annual Meeting of the Society-for-Investigative-Dermatology (SID), AZ, Scottsdale, 11 May 2016 - 14 May 2016, http://dx.doi.org/10.1016/j.jid.2016.02.163
,2016, 'A beneficial role for colchicine in reducing granulation tissue in junctional epidermolysis bullosa which caused anaemia after silicone dressings were started', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 59 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200156&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'A rare case of urethral involvement in erythema multiforme (EM) major', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200157&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'A review of physical therapies for the management of pruritus', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 42 - 42, presented at AUSTRALASIAN JOURNAL OF DERMATOLOGY, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'BP230-type bullous pemphigoid (a new disease entity?): A case series and a review of literature', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 29 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Multiple pyogenic granulomas arising spontaneously within large capillary vascular malformations during pregnancy', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Neoadjuvant treatment with vismodegib of a patient with a giant locally advanced basal cell carcinoma', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 53 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Novel and recurrent keratin 5 and keratin 14 mutations in 38 families with epidermolysis bullosa simplex in Australia', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 30 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Teledermatology satisfaction in children with epidermolysis bullosa', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Validation of a novel grey-scale and atopic dermatitis scores for skin of colour patients - Results from a multi-center study', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 85 - 85, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Validation of outcome measures for pemphigus: A systematic review using the COSMIN criteria', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 57, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374686200079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Neonatal Autoimmune Blistering Disease: A Systematic Review', in Pediatric Dermatology, http://dx.doi.org/10.1111/pde.12859
,2015, 'Defining severity cut offs and minimal clinically important differences of the Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, NETHERLANDS, Rotterdam, Vol. 135, pp. S35 - S35, presented at 45th Annual Meeting of the European-Society-for-Dermatological-Research, NETHERLANDS, Rotterdam, 09 September 2015 - 12 September 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359739400202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Skin type VII collagen acts as a tumour suppressor by regulating TGF beta and angiogenesis', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, NETHERLANDS, Rotterdam, Vol. 135, pp. S28 - S28, presented at 45th Annual Meeting of the European-Society-for-Dermatological-Research, NETHERLANDS, Rotterdam, 09 September 2015 - 12 September 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359739400159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Validation of the Epidermolysis Bullosa Disease Activity and Scarring Index: Characterising disease severity and responsiveness to clinical change in epidermolysis bullosa', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, GA, Atlanta, Vol. 135, pp. S39 - S39, presented at Annual Meeting of the Society-for-Investigative-Dermatology, GA, Atlanta, 06 May 2015 - 09 May 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352783200229&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Post-hoc analyses of the effect of AN2728 topical ointment, 2% on atopic dermatitis-associated pruritus', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, GA, Atlanta, Vol. 135, pp. S2 - S2, presented at Annual Meeting of the Society-for-Investigative-Dermatology, GA, Atlanta, 06 May 2015 - 09 May 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358272100042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'A case series of chlorophyll-induced pseudoporphyria and proposed pathogenesis', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, Vol. 72, pp. AB213 - AB213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360942901565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'A prospective comparison study of four outcome measures for atopic dermatitis', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 56, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352562300229&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'An analysis of the rurality of patients with epidermolysis bullosa in Australia', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 56, pp. 40 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352562300106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Assessing skin diseases in patients with pigmented skin (a grey area)', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, Vol. 56, pp. 86 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352562300227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,